pubmed-article:9016776 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9016776 | lifeskim:mentions | umls-concept:C1123023 | lld:lifeskim |
pubmed-article:9016776 | lifeskim:mentions | umls-concept:C0010453 | lld:lifeskim |
pubmed-article:9016776 | lifeskim:mentions | umls-concept:C0016030 | lld:lifeskim |
pubmed-article:9016776 | lifeskim:mentions | umls-concept:C0442025 | lld:lifeskim |
pubmed-article:9016776 | lifeskim:mentions | umls-concept:C0201925 | lld:lifeskim |
pubmed-article:9016776 | lifeskim:mentions | umls-concept:C0022173 | lld:lifeskim |
pubmed-article:9016776 | lifeskim:mentions | umls-concept:C0050709 | lld:lifeskim |
pubmed-article:9016776 | lifeskim:mentions | umls-concept:C0596235 | lld:lifeskim |
pubmed-article:9016776 | lifeskim:mentions | umls-concept:C1515926 | lld:lifeskim |
pubmed-article:9016776 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:9016776 | pubmed:dateCreated | 1997-3-5 | lld:pubmed |
pubmed-article:9016776 | pubmed:abstractText | Levels of free intracellular calcium have been measured on two cell lines of cultured human fibroblasts carrying the genetic lesions occurring in Duchenne and Becker dystrophies. Both cell lines elicited a markedly higher content of the cation (98 nM and 57 nM, respectively) than control fibroblasts (35 nM). Differences toward controls were statistically significant (p < 0.01). Dystrophic fibroblasts were also found to possess a significantly reduced amount by about 50% of muscular acylphosphatase isoenzyme as compared to normal cells. As acylphosphatase was demonstrated to be involved in the regulation of Ca2+-ATPase activity from different sources, a hypothesis was formulated that could explain the disruption of calcium homeostasis as an effect of the altered acylphosphatase activity. | lld:pubmed |
pubmed-article:9016776 | pubmed:language | eng | lld:pubmed |
pubmed-article:9016776 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9016776 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9016776 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9016776 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9016776 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9016776 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9016776 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9016776 | pubmed:month | Jan | lld:pubmed |
pubmed-article:9016776 | pubmed:issn | 0006-291X | lld:pubmed |
pubmed-article:9016776 | pubmed:author | pubmed-author:RamponiGG | lld:pubmed |
pubmed-article:9016776 | pubmed:author | pubmed-author:LiguriGG | lld:pubmed |
pubmed-article:9016776 | pubmed:author | pubmed-author:BertiAA | lld:pubmed |
pubmed-article:9016776 | pubmed:author | pubmed-author:PieriAA | lld:pubmed |
pubmed-article:9016776 | pubmed:author | pubmed-author:Degl'Innocent... | lld:pubmed |
pubmed-article:9016776 | pubmed:author | pubmed-author:CecchiCC | lld:pubmed |
pubmed-article:9016776 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9016776 | pubmed:day | 13 | lld:pubmed |
pubmed-article:9016776 | pubmed:volume | 230 | lld:pubmed |
pubmed-article:9016776 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9016776 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9016776 | pubmed:pagination | 327-30 | lld:pubmed |
pubmed-article:9016776 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:9016776 | pubmed:meshHeading | pubmed-meshheading:9016776-... | lld:pubmed |
pubmed-article:9016776 | pubmed:meshHeading | pubmed-meshheading:9016776-... | lld:pubmed |
pubmed-article:9016776 | pubmed:meshHeading | pubmed-meshheading:9016776-... | lld:pubmed |
pubmed-article:9016776 | pubmed:meshHeading | pubmed-meshheading:9016776-... | lld:pubmed |
pubmed-article:9016776 | pubmed:meshHeading | pubmed-meshheading:9016776-... | lld:pubmed |
pubmed-article:9016776 | pubmed:meshHeading | pubmed-meshheading:9016776-... | lld:pubmed |
pubmed-article:9016776 | pubmed:meshHeading | pubmed-meshheading:9016776-... | lld:pubmed |
pubmed-article:9016776 | pubmed:meshHeading | pubmed-meshheading:9016776-... | lld:pubmed |
pubmed-article:9016776 | pubmed:meshHeading | pubmed-meshheading:9016776-... | lld:pubmed |
pubmed-article:9016776 | pubmed:meshHeading | pubmed-meshheading:9016776-... | lld:pubmed |
pubmed-article:9016776 | pubmed:meshHeading | pubmed-meshheading:9016776-... | lld:pubmed |
pubmed-article:9016776 | pubmed:meshHeading | pubmed-meshheading:9016776-... | lld:pubmed |
pubmed-article:9016776 | pubmed:meshHeading | pubmed-meshheading:9016776-... | lld:pubmed |
pubmed-article:9016776 | pubmed:meshHeading | pubmed-meshheading:9016776-... | lld:pubmed |
pubmed-article:9016776 | pubmed:year | 1997 | lld:pubmed |
pubmed-article:9016776 | pubmed:articleTitle | Alteration of free calcium levels and acylphosphatase muscular isoenzyme in cultured dystrophic skin fibroblasts. | lld:pubmed |
pubmed-article:9016776 | pubmed:affiliation | Department of Biochemical Sciences, Università di Firenze, Italy. | lld:pubmed |
pubmed-article:9016776 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9016776 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |